Bioactive lipids in emphysema. Decoding fat to reveal COPD phenotypes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

1. Lipidomic dysregulation within the lung parenchyma following whole-thorax lung irradiation: Markers of injury, inflammation and fibrosis detected by MALDI-MSI.Scientific reports · 2017
   Article
2. Air Pollution and Lung Function Loss: The Importance of Metabolic Syndrome.Austin journal of pulmonary and respiratory medicine · 2016
   Article
3. Erratum: Bioactive Lipids in Emphysema: Decoding Fat to Reveal COPD Phenotypes.American journal of respiratory and critical care medicine · 2015
   Article

Corrections and comments

• Comment on
  Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.2015
• Erratum issued
  Erratum: Bioactive Lipids in Emphysema: Decoding Fat to Reveal COPD Phenotypes.2015

Authors and funding

2 authors at 2 institutions in 2 countries.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as